The new material is capable of absorbing pharmaceutical drugs and allows the formation of blood vessels within the material’s pores, which increases the chances for a successful integration of the implant.
The experimental model created by IK4-CIDETEC is at the preclinical trial stage of testing.
More Articles on Ophthalmology:
Dr. David Ewing-Chow to Open Solo Practice
California Laws Prohibiting ‘One-Stop’ Optician Stores Remain Intact
American Academy of Ophthalmology Joins Choosing Wisely Campaign
